Prescription Drugs – Blog
-
Inflation Reduction Act Lowers Costs for Drug Prices Rising Faster Than Inflation
Posted by
on
One of the many goals of the Inflation Reduction Act (IRA) is to reduce prescription drug costs for millions of American seniors and their families. This is already being accomplished in a variety of ways such as, capping insulin costs to $35/month, expanding free vaccine coverage, lowering costs by requiring Medicare to negotiate drug prices […]
Filed Under:
-
Survey Shows seniors find Medicare plan marketing confusing, overwhelming & Misleading
Posted by
on
With Medicare’s Open Enrollment just around the corner (Oct 15 – Dec 7), beneficiaries, their families, and caregivers across the country are bracing for the annual on-slot of advertisements, marketing and solicitations regarding Medicare Advantage, Medigap and Part D prescription drug plans. Many find the tsunami of information and marketing confusing, overwhelming and misleading, as […]
Filed Under:
-
Medicare Covers RSV Vaccine
Posted by
on
Autumn brings many great things, such as crisp, cool nights, falling apples, pumpkin harvests and turning leaves. It also brings the beginning of cold and flu season. One way to help prevent sickness and stay healthy is to make sure you’re up-to-date with your vaccines, especially the flu shot and any COVID-19 boosters, which are […]
Filed Under:
-
First 10 drugs selected for Medicare’s Drug Price negotiation program
Posted by
on
Last summer, President Biden signed the Inflation Reduction Act of 2022 (P.L. 117-169) into law. This law makes many improvements to Medicare by expanding benefits, lowering drug costs, and improving the sustainability of the Medicare program for generations to come. The law provides meaningful financial relief for millions of people with Medicare by improving access […]
Filed Under:
-
Medicare Covers New Alzheimer’s Drug
Posted by
on
Good News! As of July 6, Medicare covers a new type of medication to treat Alzheimer’s disease more broadly. The Food and Drug Administration (FDA) gave traditional approval to the first drug of this kind, Leqembi (generic name lecanemab), for treatment in July 2023. While this drug may slow or delay symptoms of Alzheimer’s, it’s […]
Filed Under: